Curanex Pharmaceuticals Common Stock Market Value
| CURX Stock | 0.36 0.01 2.68% |
| Symbol | Curanex |
Curanex Pharmaceuticals Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Curanex Pharmaceuticals. If investors know Curanex will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Curanex Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Curanex Pharmaceuticals is measured differently than its book value, which is the value of Curanex that is recorded on the company's balance sheet. Investors also form their own opinion of Curanex Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Curanex Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Curanex Pharmaceuticals' market value can be influenced by many factors that don't directly affect Curanex Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Curanex Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Curanex Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Curanex Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Curanex Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Curanex Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Curanex Pharmaceuticals.
| 12/17/2025 |
| 01/16/2026 |
If you would invest 0.00 in Curanex Pharmaceuticals on December 17, 2025 and sell it all today you would earn a total of 0.00 from holding Curanex Pharmaceuticals Common or generate 0.0% return on investment in Curanex Pharmaceuticals over 30 days. Curanex Pharmaceuticals is related to or competes with Pulmatrix, Aspire BioPharma, Palisade Bio, Longeveron LLC, Hoth Therapeutics, Curis, and Cuprina Holdings. Curanex Pharmaceuticals is entity of United States More
Curanex Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Curanex Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Curanex Pharmaceuticals Common upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.12) | |||
| Maximum Drawdown | 33.46 | |||
| Value At Risk | (10.45) | |||
| Potential Upside | 12.12 |
Curanex Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Curanex Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Curanex Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Curanex Pharmaceuticals historical prices to predict the future Curanex Pharmaceuticals' volatility.| Risk Adjusted Performance | (0.06) | |||
| Jensen Alpha | (0.84) | |||
| Total Risk Alpha | (1.61) | |||
| Treynor Ratio | (0.43) |
Curanex Pharmaceuticals Backtested Returns
Curanex Pharmaceuticals secures Sharpe Ratio (or Efficiency) of -0.0933, which signifies that the company had a -0.0933 % return per unit of risk over the last 3 months. Curanex Pharmaceuticals Common exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Curanex Pharmaceuticals' Standard Deviation of 6.44, mean deviation of 4.65, and Risk Adjusted Performance of (0.06) to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 1.6, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Curanex Pharmaceuticals will likely underperform. At this point, Curanex Pharmaceuticals has a negative expected return of -0.6%. Please make sure to confirm Curanex Pharmaceuticals' information ratio, kurtosis, as well as the relationship between the Kurtosis and period momentum indicator , to decide if Curanex Pharmaceuticals performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.51 |
Modest predictability
Curanex Pharmaceuticals Common has modest predictability. Overlapping area represents the amount of predictability between Curanex Pharmaceuticals time series from 17th of December 2025 to 1st of January 2026 and 1st of January 2026 to 16th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Curanex Pharmaceuticals price movement. The serial correlation of 0.51 indicates that about 51.0% of current Curanex Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.51 | |
| Spearman Rank Test | 0.19 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Curanex Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Curanex Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Curanex Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Curanex Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Curanex Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Curanex Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Curanex Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Curanex Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Curanex Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Curanex Pharmaceuticals Lagged Returns
When evaluating Curanex Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Curanex Pharmaceuticals stock have on its future price. Curanex Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Curanex Pharmaceuticals autocorrelation shows the relationship between Curanex Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Curanex Pharmaceuticals Common.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Curanex Stock Analysis
When running Curanex Pharmaceuticals' price analysis, check to measure Curanex Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Curanex Pharmaceuticals is operating at the current time. Most of Curanex Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Curanex Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Curanex Pharmaceuticals' price. Additionally, you may evaluate how the addition of Curanex Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.